About this trial
This study aims to evaluate the clinical and radiographic effects of 0.2% Thymoquinone gel on bone density, bone width, and socket preservation after tooth extraction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18-50 years.
Both sexes.
Patients requiring extraction of upper posterior teeth will be recruited.
Disqualifiers
Healthy subjects with intact sockets after extraction.
Normal mouth opening and good oral hygiene.
No systemic conditions affecting bone healing.
Trial design
Parallel
Treatments tested in this trial
Gel foam
DrugPatients will receive gel foam only.
Thymoquinone gel + gel foam
DrugPatients will receive 0.2% thymoquinone gel + gel foam.
Nano-formulated 0.2% thymoquinone gel + gel foam
DrugPatients will receive nano-formulated 0.2% thymoquinone gel + gel foam.
Treatment groups
Trial outcomes
Primary outcomes
Change in alveolar bone density after tooth extraction
Alveolar bone density will be assessed radiographically using cone-beam computed tomography (CBCT). The change in bone density from baseline to the specified postoperative assessment will be compared.
Secondary outcomes
Change in alveolar bone width after tooth extraction
Alveolar bone width will be assessed radiographically using cone-beam computed tomography (CBCT). The change in alveolar ridge width from baseline to the postoperative assessment will be measured.
Change in alveolar ridge dimension after tooth extraction
Alveolar ridge dimensions will be assessed radiographically using cone-beam computed tomography (CBCT). Changes in the dimensions of the alveolar ridge following tooth extraction will be measured and compared.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.